KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baxter International (BAX) Divestments (2016 - 2025)

Historic Divestments for Baxter International (BAX) over the last 13 years, with Q4 2025 value amounting to -$84.0 million.

  • Baxter International's Divestments fell 1052.63% to -$84.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.3 billion, marking a year-over-year increase of 163009.26%. This contributed to the annual value of $3.3 billion for FY2025, which is 163009.26% up from last year.
  • Baxter International's Divestments amounted to -$84.0 million in Q4 2025, which was down 1052.63% from $3.4 billion recorded in Q1 2025.
  • In the past 5 years, Baxter International's Divestments registered a high of $3.8 billion during Q3 2023, and its lowest value of -$266.0 million during Q4 2022.
  • Its 4-year average for Divestments is $536.6 million, with a median of -$37.0 million in 2024.
  • In the last 5 years, Baxter International's Divestments soared by 5417142.86% in 2023 and then tumbled by 84285.71% in 2024.
  • Over the past 4 years, Baxter International's Divestments (Quarter) stood at -$266.0 million in 2022, then skyrocketed by 45.49% to -$145.0 million in 2023, then soared by 47.59% to -$76.0 million in 2024, then dropped by 10.53% to -$84.0 million in 2025.
  • Its Divestments stands at -$84.0 million for Q4 2025, versus $3.4 billion for Q1 2025 and -$76.0 million for Q4 2024.